Cancer Clinical Trial
Official title:
Exercise Intervention for Cancer Patients to Increase Physical Activity During Chemotherapy
NCT number | NCT04151238 |
Other study ID # | T306/2019 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | February 17, 2020 |
Est. completion date | May 8, 2020 |
Verified date | November 2022 |
Source | Turku University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Exhausting chemotherapy, adverse effects of chemotherapy and a lack of information on the benefits of physical exercise are the among the reasons for reduced physical exercise among cancer patients during chemotherapy courses. According to best current knowledge only about 10% of cancer patients in Finland are physically active during cancer treatment. In addition, only 20-30% are physically active after recovery from the treatments (Pylkkänen, 2015). There is only little awareness about the benefits of physical activity during cancer treatments. The purpose of the exercise intervention study is to increase the physical activity of patients who are on chemotherapy. The study is a pilot trial and has no control group. Internationally, exercise interventions have been studied among cancer patients on treatment for decades. The American College of Sports Medicine (ACSM) recommends that cancer patients should have 150 minutes of endurance exercise per week and at least two bouts of muscle strength exercise per week. Consequently, the exercise intervention study will have a combination of muscle power and endurance training. To reach the weekly recommended level of exercise, the cancer patients in the study will additionally have a weekly home training program containing preferentially endurance training. A literature search shows that no studies on exercise interventions during cancer treatment have been published in Finland. Thus, this thesis carries the wider implication of increasing the general knowledge on the importance of physical activity of cancer patients.
Status | Completed |
Enrollment | 8 |
Est. completion date | May 8, 2020 |
Est. primary completion date | April 16, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: - cancer patients in the age of 18-70 - in the early phase of chemotherapy - first line chemotherapy - active way of treating cancer - solid tumor (breast cancer, prostata cancer, colon cancer and melanoma) - Finnish-speaking - z=0-1 (no aids) - capable travelling to University hospital for 8 weeks twice a week - normal or poor physical activity background Exclusion Criteria: - exercise contraindications, like severe respiratory or circulatory system disease (eg. heart attack <3) - brain or bone metastasis - heterogenous group (max 4 patients per cancer diagnose) - thrombocytopenia - leukocytopenia - immuno-oncological treatments - really "athlete patients" |
Country | Name | City | State |
---|---|---|---|
Finland | Turku University hospital | Turku |
Lead Sponsor | Collaborator |
---|---|
Turku University Hospital | Turku AMK Master School |
Finland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | physical activity changes in diary | Does this exercise intervention model works for cancer patients to increase the amount of physical activity and to achieve the cancer patients exercise recommendations? (especially home-exercising) | 0 and 8 weeks, | |
Primary | questionnaire-feedback from cancer patients | Does this exercise intervention model works for cancer patients to change the amount of physical activity? Patients subjective feedback about the first exercise group model in special health care. The questions are formed in quantitative way. | 0 and 8 weeks | |
Secondary | Quality of life questionnaire (EORTC QLQ-c30) | Does the guided exercise intervention (physical activity) affect the patients quality of life during chemotherapy? The scales and single-item measures range in score from 0 to 100. High score for a functional scale represents a high / healthy level of functioning, a high score for the global health status / QoL represents a high QoL, but a high score for a symptom scale / item represents a high level of symptomatology / problems. The scale consists of three different part. | 0 and 8 weeks | |
Secondary | Fatigue questionnaire (FACIT-F) | Does the guided exercise intervention (physical activity) affect the patients fatigue during chemotherapy? The score range: 0-52 points. The bigger points the worse fatigue or more symptoms. | 0 and 8 weeks | |
Secondary | Body composition in cancer patients general view (In-Body-device) | Does exercise intervention (physical activity) cause changes in the body composition of cancer patients on chemotherapy? The device measures body mass index, fluid, fat and muscle changes. We follow up the changes in general view. | 0 and 8 weeks | |
Secondary | Endurance (submaximal treadmill test) | Does exercise intervention (physical activity) cause changes in endurance of cancer patients on chemotherapy? | 0 and 8 weeks | |
Secondary | Functional muscle power test - dynamic elevation test for upper arms | Does exercise intervention (physical activity) cause changes in muscle power of cancer patients on chemotherapy? | 0 and 8 weeks | |
Secondary | Functional muscle power test - hand pressure test | Does exercise intervention (physical activity) cause changes in muscle power of cancer patients on chemotherapy? | 0 and 8 weeks | |
Secondary | Functional muscle power test - the lower extremities by repeated squatting-standing | Does exercise intervention (physical activity) cause changes in muscle power of cancer patients on chemotherapy? | 0 and 8 weeks | |
Secondary | Functional muscle power test - the lower extremities by rising to stand on the toes | Does exercise intervention (physical activity) cause changes in muscle power of cancer patients on chemotherapy? | 0 and 8 weeks | |
Secondary | Functional muscle power test - plank-test for the body | Does exercise intervention (physical activity) cause changes in muscle power of cancer patients on chemotherapy? | 0 and 8 weeks | |
Secondary | Balance -tests in specific sway-platform (standing with both legs and only one leg in sway-platform) | Does exercise intervention (physical activity) cause changes in the balance of cancer patients on chemotherapy? | 0 and 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|